PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...

Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam.

However, left untreated, diabetic retinopathy will steadily get worse over time and start to affect your vision. Treatment can help prevent, delay, and reduce vision loss.

As India grapples with an escalating diabetes crisis, with 101 million1 diagnosed and 136 million with pre-diabetes, the ...

Diabetic retinopathy happens when elevated blood sugar levels cause damage to the blood vessels in the retina. The retina plays a crucial role in transmitting visual images to the brain.